EW monthly performance report
Check EW's monthly returns, drawdown, and seasonality trends — updated every month.
EW monthly report
—
Key takeaways
- Edwards Lifesciences (EW) closed November 2026 at $105.80, up 14.99% for the month and +23.63% over the trailing 12 months.
- Year-to-date, EW is +24.11%, outperforming the S&P 500 which has returned +11.03% YTD.
- The stock is trading +22.77% versus its 200-day moving average ($86.18), a bullish technical signal.
- Over the past three years, EW has underperformed the S&P 500 by −7.06%, with a relative strength index reading of 95.2.
- Win rate over the trailing 39 months stands at 64.1% — 25 positive months versus 14 negative months.
Edwards Lifesciences ended November 2026 at $105.80, posting a monthly return of +14.99%. The S&P 500 returned +0.19% over the same window, leaving relative performance at +14.80%.
The current quarter stands at +22.57% (Q4 2026 (QTD)), while medium-term trend remains constructive: price is +22.77% versus the 200-day moving average ($86.18).
Year-to-date, EW is +24.11% against SPY +11.03%, a gap of +13.08%. The stock is currently −0.91% below its 52-week high, with maximum 3-year drawdown at −37.53%.
| Period | EW | S&P 500 (SPY) | Excess return |
|---|---|---|---|
| 1 Day | −0.01% | −0.35% | +0.34% |
| 1 Week | +4.94% | +3.29% | +1.65% |
| 1 Month | +14.99% | +0.19% | +14.80% |
| 3 Months | +15.50% | −2.48% | +17.98% |
| 6 Months | +29.99% | +2.00% | +28.00% |
| YTD | +24.11% | +11.03% | +13.08% |
| 12 Months | +23.63% | +10.79% | +12.84% |
| 3 Years | +64.77% | +71.83% | −7.06% |
| Rank | Month | Return |
|---|---|---|
| #1 | Nov 2026 | +14.99% |
| #2 | Dec 2023 | +12.61% |
| #3 | Mar 2024 | +12.60% |
| #4 | Aug 2024 | +10.96% |
| #5 | Feb 2024 | +8.16% |
| Rank | Month | Return |
|---|---|---|
| #1 | Jul 2024 | −31.74% |
| #2 | Apr 2024 | −11.40% |
| #3 | Sep 2023 | −9.40% |
| #4 | Oct 2023 | −8.03% |
| #5 | Mar 2026 | −7.39% |
| Quarter | Return |
|---|---|
| Q3 2025 | −0.56% |
| Q4 2025 | +9.62% |
| Q1 2026 | −6.06% |
| Q2 2026 | +12.96% |
| Q3 2026 | −4.58% |
| Q4 2026 (QTD) | +22.57% |
| Year | Return |
|---|---|
| 2023 | +2.20% |
| 2024 | −2.91% |
| 2025 | +15.16% |
| 2026 | +24.11% |
| Metric | Value |
|---|---|
| 52-Week High | $106.77 (2026-11-12) |
| 52-Week Low | $74.66 (2026-02-11) |
| Current Price | $105.80 |
| 200-Day Moving Average | $86.18 |
| Price vs 200DMA | +22.77% |
| 3-Year Maximum Drawdown | −37.53% (2024-07-25) |
| Current Drawdown from 52W High | −0.91% |
| RS metric | Value |
|---|---|
| RS Index (3-year, rebased to 100) | 95.2 |
| 3-Year Excess Return vs S&P 500 | −7.06% |
| RS Peak | 124.6 (Mar 2024) |
| RS Trough | 71.1 (May 2026) |
| Status | Underperforming Benchmark |
Frequently asked questions
What was EW's return for this report period?
EW returned +14.99% in the latest monthly window ending 2026-11-12.
Has EW outperformed SPY year to date?
YTD EW: +24.11% vs SPY: +11.03%.
What is EW's 12-month return?
+23.63% over the trailing 12 months.
Is EW above or below its 200-day moving average?
Price is +22.77% versus 200DMA ($86.18).
What is the maximum drawdown in the 3-year window?
−37.53% on 2024-07-25.